Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701064 · ClinicalTrials.gov registry record · NA
Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)
A NA study of Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT00701064: Completed NA study of Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.
NCT00701064 is a NA study of Post Traumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 71 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00701064, a NA study of Post Traumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are testing novel treatments for combat PTSD: bright light exposure and negation ion exposure.
Primary Outcome
The CAPS-2 is administered by a trained clinician. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD.
Conditions Studied
Interventions
- OTHER Bright Light Exposure
- OTHER Negative Ion Generator
Study Locations (1)
Arizona
- Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2009-01-01 |
| Est. Completion | 2019-09-02 |
| Phase | NA |
What the finished NCT00701064 record still lists
NCT00701064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Bright Light Exposure is the first listed.
NCT00701064 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00701064 about?
NCT00701064 is a clinical study titled "Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)". The investigators are testing novel treatments for combat PTSD: bright light exposure and negation ion exposure.
What is the current status of trial NCT00701064?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2009-01-01. Estimated completion is 2019-09-02.
What conditions does trial NCT00701064 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT00701064?
The interventions under investigation include: Bright Light Exposure (OTHER), Negative Ion Generator (OTHER).
Who is sponsoring clinical trial NCT00701064?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00701064 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00701064's enrollment target sits among peer trials
71 151st of 262 higher than 112 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI